Accelerated drug development through combined phase 2/3 clinical trial design
Arch Ophthalmol
.
2004 Jul;122(7):1043-4.
doi: 10.1001/archopht.122.7.1043.
Authors
Emmett T Cunningham Jr
1
,
Loni da Silva
,
Evelyn M Harrison
,
Marlene W Modi
,
Denis O'Shaughnessy
,
David R Guyer
Affiliation
1
Department of Ophthalmology, New York University School of Medicine, New York 10016, USA. emmett_cunningham@yahoo.com
PMID:
15249371
DOI:
10.1001/archopht.122.7.1043
No abstract available
MeSH terms
Clinical Trials, Phase II as Topic / methods*
Clinical Trials, Phase III as Topic / methods*
Drug Design
Drug Evaluation / methods*
Drugs, Investigational*
Humans
Research Design*
Substances
Drugs, Investigational